312 related articles for article (PubMed ID: 21263462)
1. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.
Leung LW; Park MS; Martinez O; Valmas C; López CB; Basler CF
Immunol Cell Biol; 2011 Oct; 89(7):792-802. PubMed ID: 21263462
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.
Yen B; Mulder LC; Martinez O; Basler CF
J Virol; 2014 Nov; 88(21):12500-10. PubMed ID: 25142601
[TBL] [Abstract][Full Text] [Related]
3. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery.
Chang TH; Kubota T; Matsuoka M; Jones S; Bradfute SB; Bray M; Ozato K
PLoS Pathog; 2009 Jun; 5(6):e1000493. PubMed ID: 19557165
[TBL] [Abstract][Full Text] [Related]
4. The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.
Jin H; Yan Z; Prabhakar BS; Feng Z; Ma Y; Verpooten D; Ganesh B; He B
J Gen Virol; 2010 Feb; 91(Pt 2):352-61. PubMed ID: 19828757
[TBL] [Abstract][Full Text] [Related]
5. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
6. A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge.
Woolsey C; Menicucci AR; Cross RW; Luthra P; Agans KN; Borisevich V; Geisbert JB; Mire CE; Fenton KA; Jankeel A; Anand S; Ebihara H; Geisbert TW; Messaoudi I; Basler CF
Cell Rep; 2019 Sep; 28(12):3032-3046.e6. PubMed ID: 31533029
[TBL] [Abstract][Full Text] [Related]
7. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.
Luthra P; Ramanan P; Mire CE; Weisend C; Tsuda Y; Yen B; Liu G; Leung DW; Geisbert TW; Ebihara H; Amarasinghe GK; Basler CF
Cell Host Microbe; 2013 Jul; 14(1):74-84. PubMed ID: 23870315
[TBL] [Abstract][Full Text] [Related]
8. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
Cárdenas WB; Loo YM; Gale M; Hartman AL; Kimberlin CR; Martínez-Sobrido L; Saphire EO; Basler CF
J Virol; 2006 Jun; 80(11):5168-78. PubMed ID: 16698997
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.
Pinski A; Woolsey C; Jankeel A; Cross R; Basler CF; Geisbert T; Messaoudi I
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408171
[TBL] [Abstract][Full Text] [Related]
10. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.
Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF
Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165
[TBL] [Abstract][Full Text] [Related]
11. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
Yen BC; Basler CF
J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
[TBL] [Abstract][Full Text] [Related]
12. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.
Prins KC; Delpeut S; Leung DW; Reynard O; Volchkova VA; Reid SP; Ramanan P; Cárdenas WB; Amarasinghe GK; Volchkov VE; Basler CF
J Virol; 2010 Mar; 84(6):3004-15. PubMed ID: 20071589
[TBL] [Abstract][Full Text] [Related]
13. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.
Hartman AL; Ling L; Nichol ST; Hibberd ML
J Virol; 2008 Jun; 82(11):5348-58. PubMed ID: 18353943
[TBL] [Abstract][Full Text] [Related]
14. The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.
Dilley KA; Voorhies AA; Luthra P; Puri V; Stockwell TB; Lorenzi H; Basler CF; Shabman RS
PLoS One; 2017; 12(6):e0178717. PubMed ID: 28636653
[TBL] [Abstract][Full Text] [Related]
15. DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function.
Shabman RS; Leung DW; Johnson J; Glennon N; Gulcicek EE; Stone KL; Leung L; Hensley L; Amarasinghe GK; Basler CF
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S911-8. PubMed ID: 21987769
[TBL] [Abstract][Full Text] [Related]
16. Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.
Olejnik J; Forero A; Deflubé LR; Hume AJ; Manhart WA; Nishida A; Marzi A; Katze MG; Ebihara H; Rasmussen AL; Mühlberger E
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331091
[TBL] [Abstract][Full Text] [Related]
17. Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways.
Ayithan N; Bradfute SB; Anthony SM; Stuthman KS; Dye JM; Bavari S; Bray M; Ozato K
J Interferon Cytokine Res; 2014 Feb; 34(2):79-89. PubMed ID: 24102579
[TBL] [Abstract][Full Text] [Related]
18. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
19. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.
Ilinykh PA; Lubaki NM; Widen SG; Renn LA; Theisen TC; Rabin RL; Wood TG; Bukreyev A
J Virol; 2015 Aug; 89(15):7567-83. PubMed ID: 25972536
[TBL] [Abstract][Full Text] [Related]
20. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
Fanunza E; Frau A; Corona A; Tramontano E
Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
